A communication aid for patients with tracheostomies
A Mixed Method Prospective Observational Cohort Study to Test Speech Recognition Application for the Voice Impaired (SRAVI) as a Communication Aid for Acute and Critical Care Patients With Tracheostomies.
This study is testing a new speech recognition app that helps patients with tracheostomies communicate by turning their lip movements into text.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 55 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Queen's University, Belfast Academic / other |
| Locations | 1 site (Belfast, Northern Ireland) |
| Trial ID | NCT06027866 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the feasibility of a speech recognition application (SRAVI) designed to assist patients with tracheostomies in communicating. The study will involve a multi-centre prospective observational cohort design, recruiting at least 55 patients who have undergone tracheostomy in acute or critical care settings. Participants will use the SRAVI device, which translates lip movements into text, and their experiences will be explored through qualitative interviews with patients, their significant others, and healthcare professionals. Data will be collected on the frequency of SRAVI use, compliance, and any adverse events.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and over who have undergone a tracheostomy in an acute or critical care setting and can articulate words through lip movements.
Not a fit: Patients who are unable to move their lips to articulate words or those who decline consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this application could significantly enhance communication for patients with tracheostomies, reducing distress and improving care.
How similar studies have performed: While the approach is innovative, similar studies exploring communication aids for patients with tracheostomies have shown promise, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years and over * Patients who acquire a tracheostomy in acute/critical care * Patients can move lips in a way that articulates words * Able to communicate in English (a current requirement of the technology) Exclusion Criteria: -Patient declined consent
Where this trial is running
Belfast, Northern Ireland
- Wellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast — Belfast, Northern Ireland, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Bronagh Blackwood, PhD
- Email: b.blackwood@qub.ac.uk
- Phone: 028 90976379
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.